Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes
与降低剂量的白消安和氟达拉滨相比,氟达拉滨和美法仑可改善老年骨髓增生异常综合征患者的移植预后。
期刊:Transplantation and Cellular Therapy
影响因子:4.4
doi:10.1016/j.jtct.2021.08.007
Oran, Betül; Ahn, Kwang Woo; Fretham, Caitrin; Beitinjaneh, Amer; Bashey, Asad; Pawarode, Attaphol; Wirk, Baldeep; Scott, Bart L; Savani, Bipin N; Bredeson, Christopher; Weisdorf, Daniel; Marks, David I; Rizzieri, David; Copelan, Edward; Hildebrandt, Gerhard C; Hale, Gregory A; Murthy, Hemant S; Lazarus, Hillard M; Cerny, Jan; Liesveld, Jane L; Yared, Jean A; Yves-Cahn, Jean; Szer, Jeffrey; Verdonck, Leo F; Aljurf, Mahmoud; van der Poel, Marjolein; Litzow, Mark; Kalaycio, Matt; Grunwald, Michael R; Diaz, Miguel Angel; Sabloff, Mitchell; Kharfan-Dabaja, Mohamed A; Majhail, Navneet S; Farhadfar, Nosha; Reshef, Ran; Olsson, Richard F; Gale, Robert Peter; Nakamura, Ryotaro; Seo, Sachiko; Chhabra, Saurabh; Hashmi, Shahrukh; Farhan, Shatha; Ganguly, Siddhartha; Nathan, Sunita; Nishihori, Taiga; Jain, Tania; Agrawal, Vaibhav; Bacher, Ulrike; Popat, Uday; Saber, Wael